DEMİRBİLEK, H. Et Al. 2020. Clinical Characteristics and Long-term Follow-of Patients with Diabetes Due To PTF1A Enhancer Mutations. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , vol.105, no.12 .

DEMİRBİLEK, H., Cayir, A., Flanagan, S. E., Yildirim, R., Kor, Y., GÜRBÜZ, F., ... Haliloglu, B.(2020). Clinical Characteristics and Long-term Follow-of Patients with Diabetes Due To PTF1A Enhancer Mutations. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , vol.105, no.12.

DEMİRBİLEK, HÜSEYİN Et Al. "Clinical Characteristics and Long-term Follow-of Patients with Diabetes Due To PTF1A Enhancer Mutations," JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , vol.105, no.12, 2020

DEMİRBİLEK, HÜSEYİN Et Al. "Clinical Characteristics and Long-term Follow-of Patients with Diabetes Due To PTF1A Enhancer Mutations." JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , vol.105, no.12, 2020

DEMİRBİLEK, H. Et Al. (2020) . "Clinical Characteristics and Long-term Follow-of Patients with Diabetes Due To PTF1A Enhancer Mutations." JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , vol.105, no.12.

@article{article, author={HÜSEYİN DEMİRBİLEK Et Al. }, title={Clinical Characteristics and Long-term Follow-of Patients with Diabetes Due To PTF1A Enhancer Mutations}, journal={JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM}, year=2020}